<result><Target><Item><Target_ID> 501</Target_ID>
<Target_Name>Tom20 missing residues 2-28</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q15388</Target_Sequence>
<Synonyms>Mitochondrial import receptor subunit TOM20 homolog
Mitochondrial 20 kDa outer membrane protein
Outer mitochondrial membrane receptor Tom20</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4APO</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 502</Target_ID>
<Target_Name>[PA63]7 complex</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P13423</Target_Sequence>
<Synonyms>(Protective antigen)7</Synonyms>
<Target_Source>Bacillus anthracis:1392</Target_Source>
<Target_Structure>1ACC, 1T6B, 1TZN, 1TZO, 3ETB, 3INO, 3KWV, 3MHZ, 3Q8A, 3Q8B, 3Q8C, 3Q8E, 3Q8F, 3TEW, 3TEX, 3TEY, 3TEZ, 4EE2</Target_Structure>
<Comments>Bacillus anthracis secretes a three-component toxin that assembles into complexes after the individual proteins are released by the bacterium. Protective antigen (PA) is the toxin component that targets mammalian cells by binding to the cellular receptors ANTXR1 and ANTXR2. PA is processed by proteases, either in the blood or on the cell surface, into a 63 kDa fragment that can self-associate into ring-shaped heptamers, referred to as [PA63]7.</Comments>
</Item><Item><Target_ID> 503</Target_ID>
<Target_Name>Isotactic poly(methyl methacrylate), st-PMMA</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 504</Target_ID>
<Target_Name>SH3 domain of tyrosine-protein kinase Lck</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P06239 [61-121]</Target_Sequence>
<Synonyms>Tyrosine-protein kinase Lck alternative name(s):
Proto-oncogene Lck
Lymphocyte cell-specific protein-tyrosine kinase
p56-LCK
LSK
T cell-specific protein-tyrosine kinase
EC=2.7.10.2</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1BHF, 1BHH, 1CWD, 1CWE, 1FBZ, 1H92, 1IJR, 1KIK, 1LCJ, 1LCK, 1LKK, 1LKL, 1Q68, 1Q69, 1QPC, 1QPD, 1QPE, 1QPJ, 1X27, 2IIM, 2OF2, 2OF4, 2OFU, 2OFV, 2OG8, 2PL0, 2ZM1, 2ZM4, 2ZYB, 3AC1, 3AC2, 3AC3, 3AC4, 3AC5, 3AC8, 3ACJ, 3ACK, 3AD4, 3AD5, 3AD6, 3B2W, 3BRH, 3BYM, 3BYO, 3BYS, 3BYU, 3KMM, 3KXZ, 3LCK, 3MPM, 4D8K</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 505</Target_ID>
<Target_Name>HUVECs co-cultured with gastric cancer cells</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>Human umbilical vein endothelial cells co-cultured with gastric cancer cells
Co-HUVECs</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 506</Target_ID>
<Target_Name>Paclitaxel (Taxol)</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Paclitaxel (Taxol), an effective anticancer agent, is known to bind to tubulin and induce tubulin polymerization.</Comments>
</Item><Item><Target_ID> 507</Target_ID>
<Target_Name>Anti-N domain of human ACE monoclonal antibody 5F1</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 508</Target_ID>
<Target_Name>Wistar Kyoto (WKY) rats' kidney</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 509</Target_ID>
<Target_Name>Tumor endothelial cells, TEC</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 510</Target_ID>
<Target_Name>Human melanoma cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 511</Target_ID>
<Target_Name>Titanium dioxide, TiO2</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 512</Target_ID>
<Target_Name>Complement receptor type 2, Cr2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P20023</Target_Sequence>
<Synonyms>Complement C3d receptor
Epstein-Barr virus receptor, EBV receptor
CD_antigen=CD21</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1GHQ, 1LY2, 1W2R, 1W2S, 2GSX, 3OED</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 513</Target_ID>
<Target_Name>Glutathione S-transferase Mu 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P28161</Target_Sequence>
<Synonyms>GSTM2-2
GST class-mu 2
EC=2.5.1.18</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HNA, 1HNB, 1HNC, 1XW5, 1YKC, 2AB6, 2C4J, 2GTU, 3GTU, 3GUR</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 514</Target_ID>
<Target_Name>Anti-gp91-phox Monoclonal antibody CL5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 515</Target_ID>
<Target_Name>HPV-16 E7 oncoprotein (28-LNDSSEEEDEI-38)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03129 [28-38]</Target_Sequence>
<Synonyms>Protein E7</Synonyms>
<Target_Source>Human papillomavirus type 16:333760</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 516</Target_ID>
<Target_Name>PreS region of the large surface antigen (LHB)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P03138 [2-63]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979) (HBV-D):490133</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 517</Target_ID>
<Target_Name>TG1 Escherichia coli cells, E.coli</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Escherichia coli:562</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 518</Target_ID>
<Target_Name>Integrin alpha-IIb-beta-3, integrin αIIbβ3</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Integrin alpha-IIb: P08514, Integrin beta-3: P05106</Target_Sequence>
<Synonyms>Integrin alpha-IIb alternative name(s):
Platelet membrane glycoprotein IIb
GPalpha IIb, GPIIb
CD_antigen=CD41

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa, GPIIIa
CD_antigen=CD61</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>Integrin alpha-IIb: 1DPK, 1DPQ, 1KUP, 1KUZ, 1M8O, 1S4W, 1TYE, 2K1A, 2K9J, 2KNC, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3NID, 3NIF, 3NIG, 3T3M, 3T3P
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2L91, 2LJD, 2LJE, 2LJF, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG, 3T3M, 3T3P, 4G1E, 4G1M</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 519</Target_ID>
<Target_Name>Kallikrein-14, hK14</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9P0G3</Target_Sequence>
<Synonyms>Kallikrein-like protein 6, KLK-L6</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 520</Target_ID>
<Target_Name>Ligand-binding domain of androgen receptor(AR)</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P10275 [690-919]</Target_Sequence>
<Synonyms>Dihydrotestosterone receptor
Nuclear receptor subfamily 3 group C member 4</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E3G, 1GS4, 1T5Z, 1T63, 1T65, 1XJ7, 1XOW, 1XQ3, 1Z95, 2AM9, 2AMA, 2AMB, 2AO6, 2AX6, 2AX7, 2AX8, 2AX9, 2AXA, 2HVC, 2OZ7, 2PIO, 2PIP, 2PIQ, 2PIR, 2PIT, 2PIU, 2PIV, 2PIW, 2PIX, 2PKL, 2PNU, 2Q7I, 2Q7J, 2Q7K, 2Q7L, 2YHD, 2YLO, 2YLP, 2YLQ, 2Z4J, 3B5R, 3B65, 3B66, 3B67, 3B68, 3BTR, 3L3X, 3L3Z, 3RLJ, 3RLL, 3V49, 3V4A, 3ZQT, 4HLW</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 521</Target_ID>
<Target_Name>Interferon-binding domain of human p300</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms>IBD of p300</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 522</Target_ID>
<Target_Name>Anti-VP2 monoclonal antibody 2F2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 523</Target_ID>
<Target_Name>Kinase domain of VEGFR2</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P35968 [834-1162]</Target_Sequence>
<Synonyms>VEGFR2 alternative name(s):
Vascular endothelial growth factor receptor 2
Kinase insert domain receptor
Protein-tyrosine kinase receptor flk-1
Fetal liver kinase 1, FLK-1
CD_antigen=CD309
EC=2.7.10.1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1VR2, 1Y6A, 1Y6B, 1YWN, 2OH4, 2P2H, 2P2I, 2QU5, 2QU6, 2RL5, 2X1W, 2X1X, 2XIR, 3B8Q, 3B8R, 3BE2, 3C7Q, 3CJF, 3CJG, 3CP9, 3CPB, 3CPC, 3DTW, 3EFL, 3EWH, 3KVQ, 3S35, 3S36, 3S37, 3U6J, 3VHE, 3VHK, 3VID, 3VNT, 3VO3, 4AG8, 4AGC, 4AGD, 4ASD, 4ASE</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 524</Target_ID>
<Target_Name>Anti-human VEGF monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 525</Target_ID>
<Target_Name>Estrogen receptor, ER</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P03372</Target_Sequence>
<Synonyms>Estradiol receptor
ER-alpha
Nuclear receptor subfamily 3 group A member 1</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A52, 1ERE, 1ERR, 1G50, 1GWQ, 1GWR, 1HCP, 1HCQ, 1L2I, 1PCG, 1QKT, 1QKU, 1R5K, 1SJ0, 1UOM, 1X7E, 1X7R, 1XP1, 1XP6, 1XP9, 1XPC, 1XQC, 1YIM, 1YIN, 1ZKY, 2AYR, 2B1V, 2B1Z, 2B23, 2BJ4, 2FAI, 2G44, 2G5O, 2I0J, 2IOG, 2IOK, 2JF9, 2JFA, 2LLO, 2LLQ, 2OCF, 2OUZ, 2P15, 2POG, 2Q6J, 2Q70, 2QA6, 2QA8, 2QAB, 2QE4, 2QGT, 2QGW, 2QH6, 2QR9, 2QSE, 2QXM, 2QXS, 2QZO, 2R6W, 2R6Y, 2YAT, 2YJA, 3CBM, 3CBO, 3CBP, 3DT3, 3ERD, 3ERT, 3HLV, 3HM1, 3L03, 3OS8, 3OS9, 3OSA, 3Q95, 3Q97, 3UU7, 3UUA, 3UUC, 3UUD, 4AA6, 4DMA, 4IU7, 4IUI, 4IV2, 4IV4, 4IVW, 4IVY, 4IW6, 4IW8, 4IWC, 4IWF, 4JC3, 4JDD</Target_Structure>
<Comments></Comments>
</Item></Target></result>